Tc tricarbonyl glycine monomers, trimers, and pentamers were synthesized and evaluated for their radiolabeling and in vivo distribution characteristics. We synthesized a 99m Tc-tricarbonyl precursor with a low oxidation state (I). Tc-tricarbonyl glycine oligomers showed rapid renal excretion through the kidneys with a low uptake in the liver, especially of 99m Tc tricarbonyl triglycine. Furthermore, we verified that the addition of triglycine to prototype biomolecules (AGRGDS and RRPYIL) results in the improvement of radiolabeling yield. From these results, we conclude that triglycine has good characteristics for use as a bifunctional chelating sequence for a 99m Tc-tricarbonyl-based biomolecular imaging probe.
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INTRODUCTION
Molecular imaging techniques can provide biological information at the molecular level in living systems. Advances in molecular imaging techniques have been brought about by significant developments in instruments and specific imaging probes. Various imaging modalities are all successfully employed in the field of molecular imaging. Computerized tomography (CT) and magnetic resonance imaging (MRI) are still the main tools for providing structure-oriented information, while nuclear and optical imaging with the appropriate probes and reporters allow additional layers of molecular information. Despite the rapid progress of a number of imaging modalities, nuclear imaging is apremier clinical method and an advantageous approach for the in vivo tracking of biomolecules.
Technetium-99m is an ideal radionuclide for diagnostic organ imaging due to its optimum γ-energy (140 keV), short half-life (6 hr), low cost, and wide availability. After the introduction of a 99m
Tc-tricarbonyl precursor with a low oxidation state (I) , many approaches have been attempted to label a 99m Tc-tricarbonyl precursor to a biomolecule, from glucose to an antibody (Schibli et al., 2000; Alberto et al., 1996; Chen et al., 2008; Taylor et al., 2010) .
An ideal imaging probe would have high affinity and specificity for the target of interest. Peptides that target a number of disease-related receptors, as well as biomarker and the angiogenesis and apoptosis processes are in place. Small peptides have favorable pharmacokinetic and tissue distribution patterns as characterized by rapid clearance from blood and non-target tissues.
Many attempts have been made for the labeling of small peptides with 99m Tc (Park et al., 2005; Reubi, 1995; Fischman et al., 1993; McAfee and Neumann, 1996; Lee et al., 2010) .
The peptide labeling approach with Tc-tricarbonyl precursor can provide the highest possible specific activities with a minimal influence on the biologic properties of the peptide, including receptor affinity and metabolism (Egli et al., 1999) . A small peptide sequence can be added to the key amino acid sequence as bifuctional chelating moiety of various molecular-targeting biomolecules for molecular imag- ing, such as RGD peptides, somatostatin, neurotensin, etc..
In this paper, we describe the evaluation of 99m
Tc-tricarbonyl labeled glycine monomer and oligomers as a bifunctionalpeptide moiety for nuclear imaging.
MATERINALS AND METHODS
Unless otherwise stated, all solvents, amino acids and their derivatives, and chemicals were of reagent grade. CO gas (99.5%) was obtained from the Daehan Gas Co. (Seoul, Korea) and prefiltered with an oxygen trap. 99m Tc was obtained as pertechnatate by elution in an Unitech Tc-99m generator with 0.9% sodium chloride (Samyoung Unitech. Co. LTD., Korea). Gly(1), Gly-Gly-Gly(Gly(3)), Gly-GlyGly-Gly-Gly (Gly (5) Tc-tricarbonyl precursor were determined using reversedphase high-performance liquid chromatography (HPLC). The 99m Tc-tricarbonyl precursor was successfully prepared with a high radio-yields (> 95%).
HPLC conditions. Instrumentation consisted of an Agilent 1200 Series system (Agilent Technologies, Waldbronn, Germany) comprising a vacuum de-gasser, a dual pump, a temperature-controlled auto-sampler, a column oven compartment, a UV-Vis detector, and a radiometric detector. HPLC was carried out on a Nucleosil C18 (5 micron, 3.0 × 250 mm, Supelco Inc., PA, USA) maintained at ambient temperature. The mobile phase consisted of methanol (solvent B) and 0.05 M TEAP(solvent A). The HPLC gradient was made up of an isocratic elution (100% A) for the first 0~5 min; a linear gradient of 75% A/25% B to 100% A/0% B for 5~8 min; a linear gradient of 66% A/34% B to 75% A/25% B for 8~11 min; a linear gradient of 0% A/100% B to 66% A/34% B for 11~22 min; and an isocratic elution (100% B) for 22~25 min. The flow rate was 0.6 ml/min and a 10 µl aliquot was injected into the column.
Radiolabeling with 99m
Tc-tricarbonyl precursor. Labeling was performed by adding 1 ml of the prepared 99m Tc-tricarbonyl precursor to the 50 µl of Gly(1), Gly(3), and Gly(5) (10 mg/ml in saline), at room temperature. Next, the reaction vial was heated at 75 o C for 30 min. After cooling to room temperature, labeling yields were checked by radio-HPLC.
Lipophilicity of 99m
Tc-tricarbonyl Glys. The octanolwater partition coefficient of the complexes was measured in triplicate as shown below. Five-hundred µl of nitrogenpurged 0.05 M phosphate-buffered saline (PBS) (pH 7.4) was mixed together with 500 µl of n-octanol. After adding 10 µl of 99m Tc-tricarbonyl glycine monomer, trimer, and pentomer (or 99m Tc-tricarbonyl precursor), the samples were vortexed for 3 min, centrifuged at 3,000 g for 5 min using a SORVALL FRESCO centrifuge (Asheville, NC, USA), and allowed to separate the two phases. Each two-hundred µl of the PBS and octanol phases were measured in a welltype NaI(Tl) scintillation detector. The calculation was performed according to the following equation.
Animal studies. Female ICR mice (7 weeks old) were obtained from a specific pathogen-free colony at Orient, Inc. (Seoul, Korea). After quarantine and adaptation for three weeks, mice were used. The animals were housed in a room maintained at 23 ± 2 o C with 50 ± 5% relative humidity, on a 12 h light/12 h dark cycle. The animals were fed a standard animal diet and water ad libitum. All animal studies were approved by the Institutional animal Care and Use Committee at Korea Atomic Energy Research Institute (KAERI).
Micro-SPECT/CT imaging studies. The mouse was scanned with an Inveon small-animal SPECT/CT system (Siemens Medical Solutions, Knoxville, TN, USA) equipped with a 1-pinhole mouse high sensitivity collimator. The mouse was anesthetized with 2% isoflurane (positioned prone in the cradle). The micro SPECT image was acquired at 30 min after intravenous injection of 37 MBq of 99m Tc-tricarbonyl compounds. The CT scans were used for the anatomical reference. For the CT scans, the X-ray sources were used at 300 µA, and 60 kV for 15 min (one shot per projection). The CT resolution was 200 µm, and the number of acquired projections was 360.
Radiolabeling of Gly(3) added biomolecules with 99m
Tc-tricarbonyl precursor. For application of Gly(3) as an ending sequence for oligopeptides, Gly(3) added peptides were synthesized with their prototype peptides (AGT-GDS, and GGGAGRGDS; RRPYIL and GGGRRPYIL). Labeling was performed using the 99m Tc-tricarbonyl Gly(3) protocols prepared as described above.
RESULTS
Radiolabeling with 99m
Tc-tricarbonyl precursor. A 99m Tc-tricarbonyl precursor was successfully prepared using
Tc Tricarbonyl Glycine Oligomers 237 a procedure described (Park et al., 2005) . The yield was higher than 98%. An additional purification step was not required. The radiolabeling results of glycine and glycine oligomers with a 99m
Tc-tricarbonyl precursor are summarized in Table 1 . The labeling yields of three 99m Tc-tricarbonyl complexes with Gly, Gly(3), and Gly(5) were greater than 80%. Analysis by RP HPLC reveals a single peak at 10.3 min for Tc-tricarbonyl glycine and oligomersare summarized in Table 2 . The values of their noctanol/buffer partition coefficients were in the range of −0.5 to −1.6. This result indicates that these complexes are hydrophilic.
Animal studies. The SPECT images of 99m
Tc-tricarbonyl glycine and glycine oligomers in normal female ICRmiceacquired at 30 min post injection are shown in Fig. 2 . Tc-tricarbonyl Gly(5) (C) on C-18 column. HPLC conditions: Mobile phase -gradient system based on 0.05 M TEAP buffer and 100% MeOH; Column -NucleosilC-18 column (3.0 × 250 mm); Flow rate −0.6 ml/min. Tc-tricarbonyl glycinetrimer had fast blood clearances and showed most activity in the bladder and some activity in the kidneys. Both 99m Tc-tricarbonyl glycine and pentaglycine also showed fast blood clearance, but some radioactivity was retained in the liver. From these imaging studies, all three complexes of 99m Tc-tricarbonyl glycines were cleared rapidly from the body by the renal excretion, particularly 99m Tc tricarbonyl-triglycine.
Radiolabeling of Gly(3) added biomolecules with 99m
Tc-tricarbonyl precursor. The labeling yields of 99m Tctricarbonyl GGGRRPYIL was higher than 95%, whereas that of 99m Tc-tricarbonyl RRPYIL was less than 10% at 18 min. Also, 99m Tc-tricarbonyl GGGAGRGDS showed a higher labeling yield than Tc-tricarbonyl precursor with a high labeling yield.
DISCUSSION
The synthesis of peptide metalloconjugation has an important role in providing radiolabelled probes for molecular imaging and therapy (Egli et al., 1999; Psimadas et al., 2012) . Modification of native amino acid side chains with bifunctionalchelators was commonly used. This non-sitespecific approach can lead to heterogeneously labeled products with a distribution of modified sites on the peptide, including the molecular recognition site. In attempt to overcome this undesirable conjugation, currently single amino acid chelate (SAAC) systems for the incorporation of the 99m Tc-tricarbonyl-based radiopharmaceuticals have been successfully established into novel synthetic strategies (Maresca et al., 2010) . During the past decade, the field of technetium coordination chemistry has seen a rising interest in the 99m Tc-tricarbonyl core Schibli et al., 2001) . But the hydrophobicity of the metal complexes resulted in poor pharmacokinetic profile. From the classic renal functional radiopharmaceutical, 99m Tc-mercaptoacetyGly(3) (MAG 3 ), the strategy of conjugation of MAG 3 to the biomolecules has been used for biomolecules' imaging such as antibodies, affibodies, anti-sense DNA, and so on (Zhang et al., 2000; Vanderheyden et al., 2006; Liu et al., 2006; Wang et al., 2007) .
In this study, the 99m Tc-tricarbonyl labeled glycine monomer and oligomers was evaluated and addition of Gly(3) ending sequence to the biomolecules was investigated as a feasibility study. The preparation of 99m Tc-tricarbonyl-glycine oligomers was well established. Gly(3) was showed that could be radiolabeled with a Tc-tricarbonyl-Gly(3) revealed hydrophilic property in the lipophilicity test that may contribute to a rapid excretion from the body when released from a biomolecule. From the nuclear image of 99m Tc-tricarbonyl-Gly(3) in normal mice, this rapid excretion property was observed with our prediction based on the lipophilicity test.
Since Gly(3) can be added to the peptide sequence of biomoleculesit can be used in the same manner as MAG 3 . Gly(3) added biomolecule (GGGAGRGDS and GGGR-RPYIL) showed enhanced radiolabeling yield in comparison with unmodified one (AGTGDS and RRPYIL) as from 12 to 95% in case of GGGRRPYIL.
In conclusion, a facile preparation of 99m Tc-tricarbonyl glycine oligomersand Gly(3) modification of biomolecule was successfully established. The 99m Tc-tricarbonyl Gly(3) described here shows a rapid renal excretion without retention in other organs, furthermore the addition of Gly(3) to peptides showed an improved radiolabeling yield. The small animal nuclear imaging study could be useful to investigate the biodistribution of the biomolecules in living animal. Gly(3) modified peptides with the rapid whole-body clearance pharmacokinetics warrant further studies on peptidebased biomolecule imaging. Tc-tricarbonyl Gly(5) (D). Imaging instrument: Inveon SPECT/CT system (Siemens Medical Solutions) equipped with 1MHS pinhole collimator. Images were obtained at 30 minutes after 37 MBq of radiolabeled compound injection intravenously. The condition of CT scan was set as 300 microampere at 60 kilovolts for X-ray source.
